N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.
circRNAs are endogenous covalently closed circular RNAs, and previous studies have validated their key regulatory roles in malignant tumors; however, the specific role and regulatory mechanism of circ
APA
Li Q, Huang X, et al. (2025). N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.. Cancer science, 116(12), 3326-3336. https://doi.org/10.1111/cas.70203
MLA
Li Q, et al.. "N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.." Cancer science, vol. 116, no. 12, 2025, pp. 3326-3336.
PMID
40990491
Abstract
circRNAs are endogenous covalently closed circular RNAs, and previous studies have validated their key regulatory roles in malignant tumors; however, the specific role and regulatory mechanism of circNEK11 in hepatocellular carcinoma (HCC) remain unclear. Here, we discovered that circNEK11 back-spliced from exons 12, 13, 14, and 15 of the NEK11 gene is significantly upregulated in HCC tissues, especially recurrent HCC tissues. YTHDC1 functions as a reader of m6A-modified circNEK11 and facilitates its cytoplasmic export. circNEK11 promotes HCC cell oncogenic functions in vitro and HCC growth in vivo. Mechanistically, circNEK11 directly binds to miR-1236-3p to regulate GPX2 expression, thus promoting HCC progression and recurrence. Collectively, our findings suggest that circNEK11 is a potential biomarker and target for HCC diagnosis and treatment.
MeSH Terms
Carcinoma, Hepatocellular; Liver Neoplasms; Humans; RNA, Circular; MicroRNAs; Animals; Adenosine; Mice; Gene Expression Regulation, Neoplastic; Cell Line, Tumor; Disease Progression; Cell Proliferation; NIMA-Related Kinases; Mice, Nude; Male; Biomarkers, Tumor; Female; Mice, Inbred BALB C
같은 제1저자의 인용 많은 논문 (5)
- Correlation between self-regulatory fatigue and physical activity in lung cancer patients undergoing comprehensive treatment.
- Chronic nanoplastics exposure drives lung cancer progression through ATF3/PCK2 axis-mediated rewiring of truncated gluconeogenesis.
- Microenvironment-responsive EGCG-functionalized nanoplatform for synergistic photothermal-chemotherapy against triple-negative breast cancer.
- Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization.
- Durvalumab Combined With Chemotherapy and SABR Therapy in Patients With Oligometastatic Non-small Cell Lung Cancer: A Multicenter Phase 2 Study.